Zacks Investment Research upgraded shares of PALOMAR MED TEC (PMTI) from UNDERPERFORM to NEUTRAL on January 30, 2013, with a target price of $10.10.
PALOMAR MEDICAL TECHNOLOGIES INC. designs, manufactures, and markets lasers, delivery systems and related disposable products for use in cosmetic and medical procedures. The company operates in two business segments: medical products and electronic products board components.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on PALOMAR MED TEC (PMTI),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment